3.Advancing Regulatory Science. for Med
![[Image: 51BVNxuWklL.jpg]](https://m.media-amazon.com/images/I/51BVNxuWklL.jpg)
This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with
procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid
and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confdential to protect the integrity of the process. We wish to thank the following individuals for their review of this report:
Gigi Kwik Gronvall, Center for Biosecurity of UPMC
Richard Jaffe, ANSER/Analytic Services Inc.
Jon Mogford, Defense Sciences Offce, DARPA
Raymond L. Woosley, The Critical Path Institute
Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the fnal draft of the report before its release. The review of this report was overseen by Peter Honig, AstraZeneca. Appointed by the Institute of Medicine, he
was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the fnal content of this report rests entirely with the authors and the institution.
procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid
and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confdential to protect the integrity of the process. We wish to thank the following individuals for their review of this report:
Gigi Kwik Gronvall, Center for Biosecurity of UPMC
Richard Jaffe, ANSER/Analytic Services Inc.
Jon Mogford, Defense Sciences Offce, DARPA
Raymond L. Woosley, The Critical Path Institute
Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the fnal draft of the report before its release. The review of this report was overseen by Peter Honig, AstraZeneca. Appointed by the Institute of Medicine, he
was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the fnal content of this report rests entirely with the authors and the institution.
This site comply with DMCA digital copyright. We do not store files not owned by us, or without the permission of the owner. We also do not have links that lead to sites DMCA copyright infringement.
If You feel that this book is belong to you and you want to unpublish it, Please contact email: xetnghiemdakhoa@gmail.com. Thanks!